Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Other Non Operating Income (2020 - 2025)

BioAtla's Other Non Operating Income history spans 6 years, with the latest figure at -$529000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 138.9% year-over-year to -$529000.0; the TTM value through Dec 2025 reached -$302000.0, down 107.25%, while the annual FY2025 figure was -$302000.0, 107.25% down from the prior year.
  • Other Non Operating Income reached -$529000.0 in Q4 2025 per BCAB's latest filing, up from -$2.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.3 million in Q1 2025 to a low of -$2.0 million in Q3 2025.
  • Average Other Non Operating Income over 5 years is $621900.0, with a median of $724500.0 recorded in 2021.
  • Peak YoY movement for Other Non Operating Income: surged 1497.83% in 2023, then plummeted 390.79% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$250000.0 in 2021, then skyrocketed by 506.8% to $1.0 million in 2022, then skyrocketed by 58.41% to $1.6 million in 2023, then decreased by 15.58% to $1.4 million in 2024, then tumbled by 138.9% to -$529000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Other Non Operating Income are -$529000.0 (Q4 2025), -$2.0 million (Q3 2025), and -$64000.0 (Q2 2025).